Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11390674 Anti-TIM-3 antibodies and compositions

Patent 11390674 was granted and assigned to Symphogen on July, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11390674

Patent Inventor Names

Torben Gjetting0

Trine Lindsted0

Gunther Roland Galler0

Ivan David Horak0

Klaus Koefoed0

Michael Kragh0

Michael Monrad Grandal0

Mikkel Wandahl Pedersen0

...

Date of Patent

July 19, 2022

Patent Application Number

16093024

Date Filed

April 11, 2017

Patent Citations

‌

US Patent 10550181 Anti-TIM-3 antibody

Patent Citations Received

‌

US Patent 11939380 Combination therapies targeting PD-1, TIM-3, and LAG-3

Patent Primary Examiner

‌

Mark Halvorson

This invention relates to anti-TIM-3 antibodies and antibody compositions and their use in enhancing immunity in a patient, e.g., to treat cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11390674 Anti-TIM-3 antibodies and compositions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API